Hyasynth Bio Revenue and Competitors

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

  • Hyasynth Bio's estimated annual revenue is currently $1.2M per year.(i)
  • Hyasynth Bio's estimated revenue per employee is $84,000

Employee Data

  • Hyasynth Bio has 14 Employees.(i)
  • Hyasynth Bio grew their employee count by -50% last year.

Hyasynth Bio's People

NameTitleEmail/Phone
1
Co-Founder, CTOReveal Email/Phone
2
Co-founder, CSOReveal Email/Phone
3
COO and President, Co-founderReveal Email/Phone
4
CEO, Co-founderReveal Email/Phone
5
Scientist IIReveal Email/Phone
6
Research ScientistReveal Email/Phone
7
Scientist IReveal Email/Phone
8
Associate Scientist (I) - FermentationReveal Email/Phone
9
Research Associate (II)Reveal Email/Phone
10
Fermentation Research AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M90-36%$14.1MN/A
#2
$83.2M468-3%$251MN/A
#3
$14M1001%N/AN/A
#4
$14.6M0N/A$12.5MN/A
#5
$30.3M197-6%N/AN/A
#6
$0.1M6-25%$2.6MN/A
#7
$45.1M2932%N/AN/A
#8
$4.8M43-7%N/AN/A
#9
$399.3M203740%N/AN/A
#10
$44M2864%N/AN/A
Add Company

What Is Hyasynth Bio?

Biology for people. Natural molecules or derivatives make up more than half of the current drugs on the market with applications to nearly every disease known to humans. Salicylic acid, morphine, cannabinoids and insulin are a few examples. Our specialty is in producing these, and new targets, using a fast and scalable platform based on engineered microbes. We use the technologies from traditional and modern biology combined with computational analysis to develop our organisms at the fastest possible speed. This makes our platform faster and cheaper than chemical synthesis or extraction from the natural source.

keywords:N/A

N/A

Total Funding

14

Number of Employees

$1.2M

Revenue (est)

-50%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Hyasynth Bio News

2022-04-17 - This Week in European Tech: 3 new unicorns (in Sweden, the UK ...

In a special guest post Kevin Chen, co-founder & CEO of Hyasynth Bio, a precision fermentation startup producing sustainable cannabinoids,...

2022-04-17 - How CBD biomanufacturing could make Europe change and win the ...

In this special guest post Kevin Chen, Co-founder & CEO, Hyasynth Bio, a precision fermentation startup producing sustainable cannabinoids,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M14N/AN/A
#2
$1.3M14N/AN/A
#3
$1.8M14N/AN/A
#4
$2.1M14N/AN/A
#5
$1.2M14N/AN/A